Evidence map›Paper›PMID 37098543›Full record

Observational studyBMC pulmonary medicine2023

The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension-a long-term retrospective multicenter trial.

Thomas Sonnweber, Piotr Tymoszuk, Regina Steringer-Mascherbauer, Elisabeth Sigmund, Stephanie Porod-Schneiderbauer, Lisa Kohlbacher, Igor Theurl, Irene Lang, Günter Weiss, Judith Löffler-Ragg

Open access · goldAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in BMC pulmonary medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Thomas SonnweberDepartment of Internal Medicine II, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria. Thomas.Sonnweber@i-med.ac.at.ORCID http://orcid.org/0000-0002-5080-386X
Piotr TymoszukData Analytics As a Service Tirol, Daas.Tirol, Innsbruck, Austria.
Regina Steringer-MascherbauerDepartment of Cardiology, Elisabethinenkrankenhaus, Linz, Austria.
Elisabeth SigmundDepartment of Cardiology, Elisabethinenkrankenhaus, Linz, Austria.
Stephanie Porod-SchneiderbauerDepartment of Cardiology, Elisabethinenkrankenhaus, Linz, Austria.
Lisa KohlbacherDepartment of Cardiology, Medical University of Vienna, Vienna, Austria.
Igor TheurlDepartment of Internal Medicine II, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.
Irene LangDepartment of Cardiology, Medical University of Vienna, Vienna, Austria.
Günter WeissDepartment of Internal Medicine II, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.
Judith Löffler-RaggDepartment of Internal Medicine II, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.
Innsbruck Medical University · ATKrankenhaus der Elisabethinen · ATMedical University of Vienna · AT

Funding

Oesterreichische Nationalbank Project 17271
6 · The paper itself

Abstract

backgroundAccurate risk stratification in pulmonary arterial hypertension (PAH), a devastating cardiopulmonary disease, is essential to guide successful therapy. Machine learning may improve risk management and harness clinical variability in PAH.

methodsWe conducted a long-term retrospective observational study (median follow-up: 67 months) including 183 PAH patients from three Austrian PAH expert centers. Clinical, cardiopulmonary function, laboratory, imaging, and hemodynamic parameters were assessed. Cox proportional hazard Elastic Net and partitioning around medoid clustering were applied to establish a multi-parameter PAH mortality risk signature and investigate PAH phenotypes.

resultsSeven parameters identified by Elastic Net modeling, namely age, six-minute walking distance, red blood cell distribution width, cardiac index, pulmonary vascular resistance, N-terminal pro-brain natriuretic peptide and right atrial area, constituted a highly predictive mortality risk signature (training cohort: concordance index = 0.82 [95%CI: 0.75 - 0.89], test cohort: 0.77 [0.66 - 0.88]). The Elastic Net signature demonstrated superior prognostic accuracy as compared with five established risk scores. The signature factors defined two clusters of PAH patients with distinct risk profiles. The high-risk/poor prognosis cluster was characterized by advanced age at diagnosis, poor cardiac output, increased red cell distribution width, higher pulmonary vascular resistance, and a poor six-minute walking test performance.

conclusionSupervised and unsupervised learning algorithms such as Elastic Net regression and medoid clustering are powerful tools for automated mortality risk prediction and clinical phenotyping in PAH.

Indexed as

Pulmonary Arterial HypertensionFamilial Primary Pulmonary HypertensionHumansPrognosisRisk AssessmentUnsupervised Machine LearningAtypical pulmonary arterial hypertensionBiomarkersMortalityPulmonary arterial hypertensionRight-heart failureRisk assessment

Identifiers

PMID37098543
PMCPMC10131314
OpenAlexW4367044362

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.